"Scaling up biohybrid robots has been difficult due to the weak contractile force of lab-grown muscles, the risk of necrosis in thick muscle tissues, and the challenge of integrating biological actuators with artificial structures," says Shoji Takeuchi, a professor at the Tokyo University, Japan.